Hormone-therapeutics for the earliest stages of neurodegeneration
Caren Pharma develops longevity therapeutics for cognitive decline driven by aging biology.
We reformulate known agents to address a critical hallmark of aging: hormonal decline.
Our approach leverages known agents and a broadly diagnosed population to reach patients faster.
_edited.png)
